Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

Clinical trial NCT06643819 · RECRUITING

Trial details

NCT number: NCT06643819
Sponsor: Chong Kun Dang Pharmaceutical
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2024-10-14
Primary completion: 2026-03-31
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.